Enrique Galve Selected Research

Enrique Galve Research Topics

Disease

9	Cardiovascular Diseases (Cardiovascular Disease) 02/2017 - 01/2012
7	Heart Failure 11/2023 - 08/2005
6	Diabetes Mellitus 10/2016 - 01/2010
5	Hypertension (High Blood Pressure) 08/2015 - 01/2010
5	Confusion (Bewilderment) 04/2015 - 11/2014
4	Coronary Disease (Coronary Heart Disease) 06/2019 - 01/2015
3	Cardiomyopathies (Cardiomyopathy) 11/2023 - 01/2014
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2020 - 09/2004
2	Atrial Fibrillation 11/2023 - 08/2011
2	Dyslipidemias (Dyslipidemia) 10/2016 - 04/2016
2	Obesity 02/2015 - 03/2014
2	Xanthomatosis (Xanthoma) 01/2015 - 01/2015
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2015 - 01/2015
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2015 - 01/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Disease Progression 11/2023
1	Left Ventricular Dysfunction 06/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Sudden Death 06/2015
1	Kidney Diseases (Kidney Disease) 03/2014
1	Chronic Renal Insufficiency 03/2014
1	Hypertrophy 01/2014
1	Fibrosis (Cirrhosis) 01/2014
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014
1	Acute Coronary Syndrome 04/2012
1	Weight Loss (Weight Reduction) 12/2011
1	Glucose Intolerance 12/2011
1	Gynecomastia 01/2008
1	Atrial Heart Septal Defects (Atrial Septal Defect) 01/2005
1	Death (Near-Death Experience) 09/2004
1	Myocardial Infarction 01/2002

Drug/Important Bio-Agent (IBA)

7	CholesterolIBA 10/2016 - 01/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2015 - 01/2002
5	LipidsIBA 10/2016 - 02/2013
4	LDL CholesterolIBA 10/2016 - 01/2015
4	oxidized low density lipoproteinIBA 01/2016 - 12/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2012 - 08/2005
1	RivaroxabanIBA 11/2023
1	Vitamin K FDA Link 11/2023
1	pro-brain natriuretic peptide (1-76)IBA 01/2020
1	Natriuretic PeptidesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	PCSK9 InhibitorsIBA 06/2019
1	IvabradineIBA 01/2018
1	Mineralocorticoid Receptor AntagonistsIBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 02/2017
1	Atorvastatin (Lipitor)FDA Link 02/2017
1	Ramipril (Altace)FDA LinkGeneric 02/2017
1	Blood Glucose (Blood Sugar)IBA 04/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2016
1	Sodium-Glucose Transport ProteinsIBA 02/2015
1	SolutionsIBA 02/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2015
1	Endothelin-1 (Endothelin 1)IBA 01/2014
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Triglycerides (Triacylglycerol)IBA 12/2011
1	AnticoagulantsIBA 08/2011
1	Renin InhibitorsIBA 01/2010
1	aliskiren FDA Link 01/2010
1	Eplerenone (Inspra)FDA LinkGeneric 01/2008
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 08/2005
1	DiureticsIBA 08/2005
1	ReninIBA 08/2005
1	Atrial Natriuretic Factor (ANF)IBA 08/2005
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2005
1	Radioisotopes (Radionuclides)IBA 09/2004

Therapy/Procedure

7	Therapeutics 06/2018 - 10/2013
3	Secondary Prevention 06/2018 - 06/2015
3	Cardiac Rehabilitation 02/2015 - 02/2013
2	Defibrillators (Defibrillator) 06/2018 - 06/2015
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2018 - 06/2015
2	Glycemic Control 04/2016 - 01/2010
2	Denervation 08/2015 - 02/2015
1	Heart Transplantation (Grafting, Heart) 01/2020
1	Heart-Assist Devices 01/2020
1	Cardiac Resynchronization Therapy 06/2018
1	Cannula 10/2013
1	Length of Stay 04/2012